Earnings whispers in the market suggest GMED could post EPS ahead of consensus, which might drive post-report rallies. This optimism is factored into the GMED stock price forecast models tracking near-term upside catalysts. Globus Medical, Inc.'s ( NYSE:GMED ) strong earnings report was rewarded with a positive stock price move. We did some digging and found some further encouraging factors that investors will like. ExcelsiusHub offers several differentiated functionalities, including elevated safety features paired with navigational accuracy, designed to enhance patient safety, such as patient array shift tracking and navigation of the DuraPro Oscillating System. It also offers imaging versatility with three distinct workflows — automatic registration with Excelsius3D, CT to fluoroscopy merging, and intraoperative 2D navigation. ExcelsiusHub is designed to navigate best-in-class Globus Medical instruments and implants for a complete procedural solution from the cervical spine to the sacrum. Fibonacci retracement levels place GMED’s key support at $60.30 and next resistance at $66.